Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study Utilizing Focal Radiation in Patients With 1-3 Brain Metastases

NCT00589212 is registered in ClinicalTrials.gov with Hologic, Inc. as lead sponsor.

NCT NCT00589212
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00589212 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study Utilizing Focal Radiation in Patients With 1-3 Brain Metastases
Lead sponsor
Hologic, Inc.
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2003
Completion date
March 31, 2008
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases